Temporary G codes are assigned to services and procedures that are under review before being included in the CPT coding system. Payment for these services is under the jurisdiction of the local carriers.

View All HCPCS Sections

• G9774

  Patients who have had a hysterectomy

• G9775

  Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

• G9776

  Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)

• G9777

  Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

• G9778

  Patients who have a diagnosis of pregnancy at any time during the measurement period

• G9779

  Patients who are breastfeeding at any time during the performance period

• G9780

  Patients who have a diagnosis of rhabdomyolysis at any time during the performance period

• G9781

  Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)

• G9782

  History of or active diagnosis of familial hypercholesterolemia

• G9783

  Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy

• G9784

  Pathologists/dermatopathologists providing a second opinion on a biopsy

• G9785

  Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist

• G9786

  Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist

• G9787

  Patient alive as of the last day of the measurement year

• G9788

  Most recent bp is less than or equal to 130/80 mm hg

• G9789

  Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits

• G9790

  Most recent bp is greater than 130/80 mm hg, or blood pressure not documented

• G9791

  Most recent tobacco status is tobacco free

• G9792

  Most recent tobacco status is not tobacco free

• G9793

  Patient is currently on a daily aspirin or other antiplatelet

• G9794

  Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)

• G9795

  Patient is not currently on a daily aspirin or other antiplatelet

• G9796

  Patient is currently on a high intensity statin therapy

• G9797

  Patient is not on a high intensity statin therapy

• G9798

  Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period

• G9799

  Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period

• G9800

  Patients who are identified as having an intolerance or allergy to beta-blocker therapy

• G9801

  Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis

• G9802

  Patients who use hospice services any time during the measurement period

• G9803

  Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

• G9804

  Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami

• G9805

  Patients who use hospice services any time during the measurement period

• G9806

  Patients who received cervical cytology or an hpv test

• G9807

  Patients who did not receive cervical cytology or an hpv test

• G9808

  Any patients who had no asthma controller medications dispensed during the measurement year

• G9809

  Patients who use hospice services any time during the measurement period

• G9810

  Patient achieved a pdc of at least 75% for their asthma controller medication

• G9811

  Patient did not achieve a pdc of at least 75% for their asthma controller medication

• G9812

  Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure

• G9813

  Patient did not die within 30 days of the procedure or during the index hospitalization

• G9814

  Death occurring during the index acute care hospitalization

• G9815

  Death did not occur during the index acute care hospitalization

• G9816

  Death occurring after discharge from the hospital but within 30 days post procedure

• G9817

  Death did not occur after discharge from the hospital within 30 days post procedure

• G9818

  Documentation of sexual activity

• G9819

  Patients who use hospice services any time during the measurement period

• G9820

  Documentation of a chlamydia screening test with proper follow-up

• G9821

  No documentation of a chlamydia screening test with proper follow-up

• G9822

  Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)

• G9823

  Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/26/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.